Reply #1: That roll call is really mixed

[karynnj]

My guess looking at it and seeing Harkin, Murray and Durbin there is that it might be a poison bill to the Agriculture bill. (The two NJ Senators, who are usually safe votes are not on this because of the huge NJ drug industry.

I actually wonder if they can regulate medicine under patent - which have a monopoly. The reason they are cheaper in Canada is because the same drug company sells them for far less. Some are even made in USA, trucked to Canada and sold cheaper there - which would make no sense if they were not a monopoly. It seems they want to recover all their research costs and much of their profit on US sales - so it is more expensive here. It seems silly to reimport when there may be a way to address the inequality. Why are they selling it for less elsewhere?